These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5972 related articles for article (PubMed ID: 3510738)
1. Adjuvant chemotherapy--clinical trials and laboratory models. Wittes RE Cancer Treat Rep; 1986 Jan; 70(1):87-103. PubMed ID: 3510738 [No Abstract] [Full Text] [Related]
2. Body burden of cancer in relationship to therapeutic outcome: consideration of preclinical evidence. Griswold DP Cancer Treat Rep; 1986 Jan; 70(1):81-6. PubMed ID: 3943116 [No Abstract] [Full Text] [Related]
3. Dose intensity versus total dose of chemotherapy: an experimental basis. Skipper HE Important Adv Oncol; 1990; ():43-64. PubMed ID: 2182523 [No Abstract] [Full Text] [Related]
5. [Effect of antineoplastic agents on strains of human breast carcinoma and chorioepithelioma transplanted into nude mice]. Revazova ES Vestn Akad Med Nauk SSSR; 1981; (9):79-83. PubMed ID: 7197438 [No Abstract] [Full Text] [Related]
6. Clinical concepts derived from animal chemotherapy studies. Goldin A; Schabel FM Cancer Treat Rep; 1981; 65 Suppl 3():11-9. PubMed ID: 7049366 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapeutic strategies for neoplasia. Talmadge JE Dev Biol Stand; 1992; 77():17-28. PubMed ID: 1426659 [No Abstract] [Full Text] [Related]
8. Rationale for the use of alternating non-cross-resistant chemotherapy. Goldie JH; Coldman AJ; Gudauskas GA Cancer Treat Rep; 1982 Mar; 66(3):439-49. PubMed ID: 7060033 [No Abstract] [Full Text] [Related]
9. [Dose intensification of adjuvant chemotherapy in high-risk non-metastatic breast cancer: a critical review]. Ganem G Bull Cancer; 1997 Jan; 84(1):97-105. PubMed ID: 9180866 [TBL] [Abstract][Full Text] [Related]
10. Experimental adjuvant chemotherapy: an overview. Skipper HE Recent Results Cancer Res; 1986; 103():6-29. PubMed ID: 3738196 [No Abstract] [Full Text] [Related]
11. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors. Sirotnak FM; Otter GM; Schmid FA Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192 [TBL] [Abstract][Full Text] [Related]
12. Optimal timing of adjuvant chemotherapy in mouse models. van Putten LM Prog Clin Biol Res; 1985; 201():15-21. PubMed ID: 3867900 [TBL] [Abstract][Full Text] [Related]
13. [Use of xenografts for the evaluation of tumor chemotherapy. Application to adjuvant chemotherapy]. Duplan JF Bull Cancer; 1984; 71(4):292-6. PubMed ID: 6498344 [TBL] [Abstract][Full Text] [Related]
15. Average relative dose intensity and the impact on design of clinical trials. Hryniuk WM Semin Oncol; 1987 Mar; 14(1):65-74. PubMed ID: 3823917 [No Abstract] [Full Text] [Related]
16. [Segidrin: a new-type antineoplastic agent]. Filov VA Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790 [No Abstract] [Full Text] [Related]
17. Possible benefits of hyperthermia to chemotherapy. Kowal CD; Bertino JR Cancer Res; 1979 Jun; 39(6 Pt 2):2285-9. PubMed ID: 376118 [TBL] [Abstract][Full Text] [Related]
18. Preoperative (neoadjuvant) chemotherapy in the murine Lewis lung carcinoma and possible implications for clinical use. Fichtner I; Tanneberger S Anticancer Res; 1987; 7(2):227-33. PubMed ID: 3592636 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose? Schuchter LM J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612 [No Abstract] [Full Text] [Related]
20. Trials of adjuvant chemotherapy in colorectal cancer. Gilbert JM Drugs Exp Clin Res; 1986; 12(1-3):201-10. PubMed ID: 3525074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]